Clyde Biosciences Ltd. has announced a 2 million 'Series A' investment led by Epidarex Capital, a leading international early-stage life science venture capital fund. Scottish Enterprise's investment arm, the Scottish Investment Bank, also participated in the round along with Glasgow University Holdings, Ltd. Clyde Biosciences, a spin-out company from the University of Glasgow, has developed a pioneering technology to evaluate drug toxicity for pharmaceutical and biotechnology companies.
http://ift.tt/1PJOIcZ
http://ift.tt/1PJOIcZ
No comments:
Post a Comment